2023-07-06 08:55:06 ET
- Biotechnology company Curis ( NASDAQ: CRIS ) said on Thursday that it is launching an ~$15.1M registered direct offering priced at-the-market.
- The company has entered into definitive agreements led by existing investors for the purchase of 18.4M shares at $0.82 per share.
- The net proceeds are intended to be used on research, development, working capital and other general corporate purposes.
- The offering is expected to close on or about July 10.
- CRIS shares were trading -8.58% pre-market.
- Source: Press Release
For further details see:
Curis launches ~$15.1M registered direct offering